Intelligence · Drug directory
Pipeline & Investigational Drugs
Investigational and clinical-stage compounds without US or EU marketing approval — linked to ClinicalTrials.gov programs and congress coverage.
Quick answer
Pipeline & investigational drugs: NovaPharmaNews tracks 1,610 pharmaceutical drugs in this segment. Investigational and clinical-stage compounds without US or EU marketing approval — linked to ClinicalTrials.gov programs and congress coverage.
-
arachis hypogaea extract
ABYLQIS
V01AA08 -
arcitumomab
CEA-SCAN
V09IA01 -
arimoclomol
MIPLYFFA
N07 -
ataluren
TRANSLARNA
M09AX03 -
autologous cartilage-derived articular chondrocytes, in-vitro expanded
JELRIX
M09AX02 -
autologous glioma tumor cell lysates (inactivated)
SITOIGANAP
L01XX -
autologous human chondrocytes in vitro expanded
ARTOBEND
M09AX02 -
autologous peripheral-blood mononuclear cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor (sipuleucel-t)
PROVENGE
L03AX17 -
avacincaptad pegol
IZELVAY
S01XA32 -
bamlanivimab
BAMLANIVIMAB AND ETESEVIMAB FOR COVID-19
-
bardoxolone methyl
IMBARKYD
-
begelomab
BEGEDINA
L04AA35 -
betibeglogene autotemcel
ZYNTEGLO
B06A -
bifikafusp alfa
NIDLEGY
L01XY -
blarcamesine
BLARCAMESINE ANAVEX
N06D -
briakinumab
OZESPA
L04AC09 -
camizestrant
ETCAMAH
L02BA05 -
carisbamate
COMFYDE
-
casirivimab
RONAPREVE
J06BD07 -
casopitant
ZUNRISA
-
cediranib maleate
ZEMFIRZA
L01XE32 -
ceftobiprole
ZEFTERA (PREVIOUSLY ZEVTERA)
J01DI01 -
characterised viable autologous cartilage cells expanded ex vivo expressing specific marker proteins
CHONDROCELECT
M09AX02 -
clostridium botulinum, serotype e, neurotoxin (150 kda)
BOEY
M03AX01
Frequently asked questions
How many pipeline drugs are listed?
1,610 drug profiles match this regulatory segment in our published index.
Where does approval data come from?
Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.